Tscan Therapeutics shares owned by Propel Bio Management
Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Propel Bio Management
from 13F filings
Historical chart of Propel Bio Management investment in Tscan Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Tscan Therapeutics held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Tscan Therapeutics by Propel Bio Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.5M | 1.9M | 1.82 |
| 2025-06-30 | $3.0M | 2.1M | 1.45 |
| 2025-03-31 | $2.9M | 2.1M | 1.38 |
| 2024-12-31 | $6.3M | 2.1M | 3.04 |
| 2024-09-30 | $10M | 2.1M | 4.98 |
| 2024-06-30 | $12M | 2.1M | 5.85 |
| 2024-03-31 | $17M | 2.1M | 7.94 |
| 2023-12-31 | $12M | 2.1M | 5.83 |